nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—KCNK1—adrenal cortex—bipolar disorder	0.0208	0.104	CbGeAlD
Quinidine barbiturate—CYP2D6—urine—bipolar disorder	0.0176	0.0882	CbGeAlD
Quinidine barbiturate—KCNK1—thyroid gland—bipolar disorder	0.0145	0.0727	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—bipolar disorder	0.0122	0.0611	CbGeAlD
Quinidine barbiturate—KCNK1—cerebellum—bipolar disorder	0.0115	0.0575	CbGeAlD
Quinidine barbiturate—Phenobarbital—GRIK2—bipolar disorder	0.0108	1	CrCbGaD
Quinidine barbiturate—GRIA2—nervous system—bipolar disorder	0.0099	0.0497	CbGeAlD
Quinidine barbiturate—GRIA2—cerebellum—bipolar disorder	0.00932	0.0468	CbGeAlD
Quinidine barbiturate—KCNK1—brain—bipolar disorder	0.0093	0.0467	CbGeAlD
Quinidine barbiturate—CYP2D6—blood plasma—bipolar disorder	0.00916	0.046	CbGeAlD
Quinidine barbiturate—GRIA2—brain—bipolar disorder	0.00757	0.038	CbGeAlD
Quinidine barbiturate—SCN5A—nervous system—bipolar disorder	0.00727	0.0365	CbGeAlD
Quinidine barbiturate—GABRA2—nervous system—bipolar disorder	0.00644	0.0323	CbGeAlD
Quinidine barbiturate—GABRA1—nervous system—bipolar disorder	0.00622	0.0312	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—bipolar disorder	0.00619	0.0311	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—bipolar disorder	0.00606	0.0304	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—bipolar disorder	0.00585	0.0294	CbGeAlD
Quinidine barbiturate—SCN5A—brain—bipolar disorder	0.00556	0.0279	CbGeAlD
Quinidine barbiturate—GABRA2—brain—bipolar disorder	0.00492	0.0247	CbGeAlD
Quinidine barbiturate—GABRA1—brain—bipolar disorder	0.00475	0.0239	CbGeAlD
Quinidine barbiturate—CHRM2—brain—bipolar disorder	0.00473	0.0238	CbGeAlD
Quinidine barbiturate—KCNH2—nervous system—bipolar disorder	0.00447	0.0224	CbGeAlD
Quinidine barbiturate—KCNH2—cerebellum—bipolar disorder	0.00421	0.0211	CbGeAlD
Quinidine barbiturate—KCNH2—brain—bipolar disorder	0.00342	0.0172	CbGeAlD
Quinidine barbiturate—CYP2D6—nervous system—bipolar disorder	0.00273	0.0137	CbGeAlD
Quinidine barbiturate—CYP2D6—cerebellum—bipolar disorder	0.00256	0.0129	CbGeAlD
Quinidine barbiturate—CYP2D6—brain—bipolar disorder	0.00208	0.0105	CbGeAlD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.00204	0.00259	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00203	0.00257	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—TRPC3—bipolar disorder	0.00202	0.00256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—DRD4—bipolar disorder	0.00201	0.00255	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—bipolar disorder	0.00201	0.00255	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.002	0.00253	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00197	0.00249	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.00196	0.00248	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00196	0.00248	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NCAN—bipolar disorder	0.00194	0.00246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.00191	0.00242	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ANK3—bipolar disorder	0.0019	0.00241	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.0019	0.0024	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNB2—bipolar disorder	0.00188	0.00238	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SNAP25—bipolar disorder	0.00186	0.00235	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00186	0.00235	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.00184	0.00233	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00184	0.00233	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GRIK2—bipolar disorder	0.00184	0.00233	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00183	0.00231	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.00182	0.00231	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.00181	0.00229	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GRIN1—bipolar disorder	0.0018	0.00228	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00178	0.00225	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00178	0.00225	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00178	0.00225	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GAD1—bipolar disorder	0.00176	0.00223	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—bipolar disorder	0.00175	0.00222	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—RGS4—bipolar disorder	0.00175	0.00221	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.00174	0.0022	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.00174	0.0022	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00173	0.00219	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.00173	0.00219	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNA1C—bipolar disorder	0.00172	0.00218	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—bipolar disorder	0.00171	0.00217	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.00171	0.00216	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—GRIN2B—bipolar disorder	0.00168	0.00213	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00168	0.00212	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SLC6A3—bipolar disorder	0.00166	0.0021	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00165	0.00209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00165	0.00209	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00165	0.00209	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—ADCY2—bipolar disorder	0.00165	0.00208	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SNAP25—bipolar disorder	0.00164	0.00208	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CACNB2—bipolar disorder	0.00164	0.00207	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00162	0.00205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.00161	0.00204	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.0016	0.00203	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00159	0.00202	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GRIK2—bipolar disorder	0.00157	0.00198	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—GSK3B—bipolar disorder	0.00156	0.00197	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00155	0.00196	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GRIN1—bipolar disorder	0.00153	0.00194	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.00152	0.00193	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00151	0.00191	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GAD1—bipolar disorder	0.0015	0.0019	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GRIN2B—bipolar disorder	0.00148	0.00188	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GRIN1—bipolar disorder	0.00147	0.00186	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SLC6A3—bipolar disorder	0.00146	0.00185	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.00146	0.00184	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—ADCY2—bipolar disorder	0.00145	0.00184	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TRPC3—bipolar disorder	0.00144	0.00183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.00144	0.00182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.00142	0.0018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00141	0.00179	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—COMT—bipolar disorder	0.00141	0.00178	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAOA—bipolar disorder	0.0014	0.00177	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CACNB2—bipolar disorder	0.0014	0.00177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00139	0.00176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00139	0.00176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00139	0.00176	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—GRIN2B—bipolar disorder	0.00136	0.00172	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.00135	0.00171	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNB2—bipolar disorder	0.00134	0.0017	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00134	0.00169	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00132	0.00167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—HTR2A—bipolar disorder	0.00131	0.00166	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SNAP25—bipolar disorder	0.00131	0.00166	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.0013	0.00164	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00129	0.00164	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00129	0.00163	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00129	0.00163	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00129	0.00163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00128	0.00162	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00125	0.00158	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—COMT—bipolar disorder	0.00124	0.00158	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAOA—bipolar disorder	0.00124	0.00156	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNA1C—bipolar disorder	0.00123	0.00155	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GRIN2B—bipolar disorder	0.00118	0.0015	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SLC6A3—bipolar disorder	0.00117	0.00148	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—ADCY2—bipolar disorder	0.00116	0.00147	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00114	0.00144	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SNAP25—bipolar disorder	0.00112	0.00141	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—COMT—bipolar disorder	0.0011	0.0014	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.0011	0.00139	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.0011	0.00139	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00109	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD5—bipolar disorder	0.00108	0.00136	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00107	0.00135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00105	0.00132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—HTR1A—bipolar disorder	0.00104	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00101	0.00128	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GRIN2B—bipolar disorder	0.00101	0.00128	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.000997	0.00126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.000997	0.00126	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SLC6A3—bipolar disorder	0.000995	0.00126	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—COMT—bipolar disorder	0.000992	0.00126	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—ADCY2—bipolar disorder	0.000988	0.00125	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAOA—bipolar disorder	0.000985	0.00125	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000981	0.00124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD3—bipolar disorder	0.000971	0.00123	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GRIN2B—bipolar disorder	0.00097	0.00123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000963	0.00122	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00095	0.0012	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000947	0.0012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD4—bipolar disorder	0.000942	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00093	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00093	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000901	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000892	0.00113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—ADCY2—bipolar disorder	0.000887	0.00112	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000884	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD2—bipolar disorder	0.000878	0.00111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000875	0.00111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000853	0.00108	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—COMT—bipolar disorder	0.000846	0.00107	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAOA—bipolar disorder	0.00084	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000825	0.00104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000815	0.00103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000813	0.00103	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000807	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000797	0.00101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000797	0.00101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADM—bipolar disorder	0.000779	0.000986	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000772	0.000977	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TSHB—bipolar disorder	0.000759	0.000961	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TACR1—bipolar disorder	0.000759	0.000961	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000749	0.000948	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—GSK3B—bipolar disorder	0.000742	0.00094	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000716	0.000907	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000698	0.000883	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DGKH—bipolar disorder	0.000666	0.000843	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000646	0.000818	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR1A—bipolar disorder	0.000628	0.000795	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000627	0.000794	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000623	0.000788	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TAC1—bipolar disorder	0.000619	0.000783	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD5—bipolar disorder	0.000609	0.000771	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2C—bipolar disorder	0.000607	0.000768	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD1—bipolar disorder	0.000607	0.000768	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DGKH—bipolar disorder	0.000605	0.000765	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RGS4—bipolar disorder	0.000597	0.000756	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—COMT—bipolar disorder	0.000589	0.000745	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD3—bipolar disorder	0.000588	0.000744	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOA—bipolar disorder	0.000585	0.00074	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	0.000581	0.000735	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000571	0.000722	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD4—bipolar disorder	0.000571	0.000722	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD5—bipolar disorder	0.000553	0.0007	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RGS4—bipolar disorder	0.000542	0.000686	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000535	0.000677	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD2—bipolar disorder	0.000532	0.000673	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000531	0.000672	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GSK3B—bipolar disorder	0.00053	0.00067	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—INS—bipolar disorder	0.000523	0.000661	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000506	0.00064	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IMPA2—bipolar disorder	0.000504	0.000638	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—bipolar disorder	0.000491	0.000622	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000489	0.000619	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TRPC3—bipolar disorder	0.000461	0.000584	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADM—bipolar disorder	0.00044	0.000557	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TSHB—bipolar disorder	0.000429	0.000543	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PDE4B—bipolar disorder	0.000429	0.000543	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TACR1—bipolar disorder	0.000429	0.000543	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TRPC3—bipolar disorder	0.000419	0.00053	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADM—bipolar disorder	0.0004	0.000506	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00039	0.000494	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TSHB—bipolar disorder	0.00039	0.000493	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PDE4B—bipolar disorder	0.00039	0.000493	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TACR1—bipolar disorder	0.00039	0.000493	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKR1C4—bipolar disorder	0.000388	0.000491	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—bipolar disorder	0.000381	0.000482	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—bipolar disorder	0.000372	0.000471	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DGKH—bipolar disorder	0.000357	0.000452	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR1A—bipolar disorder	0.000355	0.000449	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TAC1—bipolar disorder	0.00035	0.000443	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD1—bipolar disorder	0.000343	0.000434	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2C—bipolar disorder	0.000343	0.000434	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.00034	0.000431	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD3—bipolar disorder	0.000332	0.00042	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD5—bipolar disorder	0.000327	0.000413	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR1A—bipolar disorder	0.000322	0.000408	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD4—bipolar disorder	0.000322	0.000408	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RGS4—bipolar disorder	0.00032	0.000405	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TAC1—bipolar disorder	0.000318	0.000402	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD1—bipolar disorder	0.000311	0.000394	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2C—bipolar disorder	0.000311	0.000394	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000304	0.000384	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD3—bipolar disorder	0.000302	0.000382	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD2—bipolar disorder	0.0003	0.00038	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—bipolar disorder	0.000297	0.000376	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD4—bipolar disorder	0.000293	0.000371	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.000289	0.000366	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKR1C4—bipolar disorder	0.00028	0.000355	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADCY2—bipolar disorder	0.000276	0.000349	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD2—bipolar disorder	0.000273	0.000345	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NR1D1—bipolar disorder	0.000252	0.000319	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRPC3—bipolar disorder	0.000248	0.000313	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCAN—bipolar disorder	0.000241	0.000305	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADM—bipolar disorder	0.000236	0.000299	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.000236	0.000299	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSHB—bipolar disorder	0.00023	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	0.00023	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TACR1—bipolar disorder	0.00023	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	0.00021	0.000266	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	0.000191	0.000242	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	0.00019	0.000241	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TAC1—bipolar disorder	0.000188	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	0.000184	0.000233	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD1—bipolar disorder	0.000184	0.000233	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	0.000179	0.000227	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD3—bipolar disorder	0.000178	0.000226	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	0.000177	0.000225	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD4—bipolar disorder	0.000173	0.000219	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CLOCK—bipolar disorder	0.000171	0.000216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	0.000168	0.000213	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPH2—bipolar disorder	0.000166	0.00021	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TSHB—bipolar disorder	0.000166	0.00021	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNB2—bipolar disorder	0.000166	0.00021	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DPYD—bipolar disorder	0.000163	0.000207	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	0.000163	0.000206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	0.000162	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD2—bipolar disorder	0.000161	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—bipolar disorder	0.000153	0.000193	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNA1C—bipolar disorder	0.000152	0.000192	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	0.000148	0.000187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	0.000146	0.000185	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—S100B—bipolar disorder	0.000142	0.00018	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SNAP25—bipolar disorder	0.000133	0.000168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRG1—bipolar disorder	0.000125	0.000158	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADCY2—bipolar disorder	0.000118	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	0.000113	0.000143	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—bipolar disorder	0.000101	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOA—bipolar disorder	0.0001	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	9.09e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—bipolar disorder	9.01e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—bipolar disorder	8.96e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—bipolar disorder	8.14e-05	0.000103	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—bipolar disorder	6.51e-05	8.24e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—bipolar disorder	6.47e-05	8.19e-05	CbGpPWpGaD
